Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.33 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.31 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.31 |
| ▸ | WNT3A | P56704 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MC4R | P32245 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | MC3R | P41968 | 1/20 | 0.31 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.30 |
| ▸ | IKBKB | O14920 | 1/20 | 0.30 |
| ▸ | CHUK | O15111 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrazole SCHEMBL358845 | 0.82 | NAPRT (0.36) | P2RX7KDM4ECTNNB1WNT3ATSHR | |
| Pyrazole SCHEMBL1129000 | 0.81 | — | — | |
| SCHEMBL158178 | 0.81 | — | — | |
| Pyrazole SCHEMBL28727019 | 0.79 | — | — | |
| Pyrazole SCHEMBL440249 | 0.79 | — | — | |
| Pyrazole SCHEMBL2511053 | 0.79 | CES2 (0.48) | RAB9A | |
| Hydrochloric Acid SCHEMBL25337662 | 0.79 | P2RX7 (0.52) | P2RX7PARP1PARP10MKNK1MKNK2 | |
| Ammonia Solution, Strong SCHEMBL17104818 | 0.79 | P2RX7 (0.52) | P2RX7PARP1PARP10MKNK1MKNK2 | |
| Hydrochloric Acid SCHEMBL27440453 | 0.79 | P2RX7 (0.52) | P2RX7PARP1PARP10MKNK1MKNK2 | |
| SCHEMBL27431959 | 0.79 | P2RX7 (0.52) | P2RX7PARP1PARP10MKNK1MKNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115551859-B | Aza condensed ring amide compound and application thereof | 石药集团中奇制药技术(石家庄)有限公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-106232794-B | Fabric care compositions comprising polyurethane, polyurea and/or polyurethaneurea polymers | 宝洁公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-115551859-A | Aza condensed ring amide compound and application thereof | 石药集团中奇制药技术(石家庄)有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-107743421-B | Apparatus and method for applying a composition to a surface | 宝洁公司 | 2021-02-09 | — | — | CN | disclosed |
| CN-106164235-B | Cleaning compositions comprising polyetheramines | 宝洁公司 | 2020-01-31 | — | — | CN | disclosed |
| CN-110003219-A | Pyrazolo [1,5A] pyrimidine and thieno [3,2B] pyrimidine derivatives as IRAK4 regulator | 弗·哈夫曼-拉罗切有限公司 | 2019-07-12 | — | — | CN | disclosed |
| CN-105367577-B | Pyrazolo [1,5A] pyrimidine and thieno [3,2B] pyrimidine derivatives as IRAK4 regulator | 弗·哈夫曼-拉罗切有限公司 | 2019-04-23 | — | — | CN | disclosed |
| US-20190091195-A1 | USE OF DIANHYDROGALACTITOL AND DERIVATIVES THEREOF IN THE TREATMENT OF GLIOBLASTOMA, LUNG CANCER, AND OVARIAN CANCER | DEL MAR PHARMACEUTICALS (CA) | 2019-03-28 | — | — | US | disclosed |
| US-20180298026-A1 | Pyrazolo[1,5a]Pyrimidine Derivatives as IRAK4 Modulators | HOFFMANN-LA ROCHE INC. | 2018-10-18 | — | — | US | disclosed |
| US-10023589-B2 | Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators | HOFFMANN-LA ROCHE INC. (US) | 2018-07-17 | — | — | US | disclosed |
| CN-102612553-A | High-efficiency capsules comprising benefit agents | PROCTER & GAMBLE | 2012-07-25 | — | — | CN | disclosed |
| CN-102575198-A | A laundry detergent composition comprising a highly water-soluble carboxymethyl cellulose particle | PROCTER & GAMBLE | 2012-07-11 | — | — | CN | disclosed |
| US-20120015962-A1 | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | ARORA NIDHI (US) | 2012-01-19 | — | — | US | disclosed |
| WO-2012007375-A1 | PYRAZOLO [1, 5A] PYRIMIDINE AND THIENO [3, 2B] PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2012-01-19 | — | — | WO | disclosed |
| CN-102112602-A | Detergent compositions comprising lipase | PROCTER & GAMBLE | 2011-06-29 | — | — | CN | disclosed |
| CN-101960007-A | Detergent composition comprising lipase | PROCTER & GAMBLE | 2011-01-26 | — | — | CN | disclosed |
| CN-101910392-A | Enzyme and fabric hueing agent containing compositions | PROCTER & GAMBLE | 2010-12-08 | — | — | CN | disclosed |
| CN-101490230-A | Detergent compositions | PROCTER & GAMBLE (US) | 2009-07-22 | — | — | CN | disclosed |
| CN-101374934-A | Enzyme and fabric hueing agent containing compositions | PROCTER & GAMBLE (US) | 2009-02-25 | — | — | CN | disclosed |
| CN-101370920-A | Detergent compositions | PROCTER & GAMBLE (US) | 2009-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10023589-B2 | Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators | IRAK4, IRAK1, IRAK2 | P2RX7 254/4885CSNK1A1 186/4885TYRO3 516/4885 |
| US-20190091195-A1 | USE OF DIANHYDROGALACTITOL AND DERIVATIVES THEREOF IN THE TREATMENT OF GLIOBLASTOMA, LUNG CANCER, AND OVARIAN CANCER | DDOST, DCLRE1A, OGG1 | P2RX7 2735/4885CSNK1A1 4559/4885TYRO3 4756/4885 |
| US-20120015962-A1 | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | IRAK4, IRAK1, IRAK2 | P2RX7 254/4885CSNK1A1 186/4885TYRO3 516/4885 |
| US-20180298026-A1 | Pyrazolo[1,5a]Pyrimidine Derivatives as IRAK4 Modulators | IRAK4, IRAK1, IRAK2 | P2RX7 254/4885CSNK1A1 186/4885TYRO3 516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.